secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2026-08-10T10:50:13+00:00
Accession:  0001104659-26-092999
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accendra Health Q2 revenue down 10%, adjusted loss; CEO Pesicka to retire by end of 2026
--------------------------------------------------------------------------------

- Q2 net revenue $613.2M, down 10% YoY from $681.9M; GAAP EPS -$1.16 vs -$1.09.
- Adjusted EBITDA $60.1M vs $96.6M; adjusted EPS -$0.19 vs +$0.26; free cash flow -$25.1M.
- Reduced total debt by $385M in Q2 via balance sheet optimization closed in June.
- CEO Ed Pesicka to retire by end of 2026; will step down from Board; succession process underway.
- Eliminated over $125M annualized operating expense from large commercial payor exit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/0001104659-26-092999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/tm2622667d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-092999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer